In 2025, Korea’s medical industry has entered a new era, surpassing $20 billion in exports and emerging as a key force in the global market. As of the third quarter, cumulative exports reached $7.88 billion for pharmaceuticals, $4.43 billion for medical devices, and $8.5 billion for cosmetics—an all-time high across every sector. These achievements underscore that Korea’s biomedical technology has firmly established itself as a trusted ‘global partner’ across the United States, Europe, the Middle East, and Asia.
What stands out most is the acceleration of technological convergence in each field. AI-powered diagnostic systems and precision surgical robots are now being deployed in medical institutions across advanced economies, transforming the global landscape for high-end medical devices. Meanwhile, the fast-growing cosmeceutical industry—where cosmetic and pharmaceutical technologies intersect—is rapidly meeting international demand…
